Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
COMPLETED
12 participants
OBSERVATIONAL
2007-06-30
2008-04-30
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
Pregnancy increases the chance that any mother may have an abnormal heart rhythm or arrhythmia. This chance is higher with the LQTS. There are only a few reported cases of women with the LQTS having a baby in the medical literature. This can make it difficult for the doctor caring for a pregnant woman with the long QT syndrome - especially should they need an anesthetic.
We would like to study as many women who have had a baby who have the long QT syndrome to give us a better idea of whether there are any arrhythmias occurring at the time of delivery.
Related Clinical Trials
Explore similar clinical trials based on study characteristics and research focus.
Influence of Sex Hormones Variation During Third Trimester of Pregnancy and Post-partum on QT Interval Duration
NCT02931695
Pregnancy and Dilated Cardiomyopathy
NCT03235063
Clinical Features, Outcomes, and Therapeutics of Pregnancy-Related Aortic Dissection
NCT05501145
qCTG and Doppler Ultrasound in the Detection of Hypoxia Among FGR Fetuses
NCT04447248
Non Syndromic Congenital Heart Defect and Array-CGH in Prenatal Diagnosis
NCT02333097
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
COHORT
RETROSPECTIVE
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
Exclusion Criteria
* Age less than 19
* Non English speaker
FEMALE
No
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
University of British Columbia
OTHER
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
University of British Columbia
Principal Investigators
Learn about the lead researchers overseeing the trial and their institutional affiliations.
Roanne Preston, MD
Role: PRINCIPAL_INVESTIGATOR
University of British Columbia
Elizabeth Drake, MD
Role: STUDY_DIRECTOR
University of British Columbia
Joanne Douglas, MD
Role: STUDY_DIRECTOR
University of British Columbia
Marla Kiess, MD
Role: STUDY_DIRECTOR
University of British Columbia
Stanley Tung, MD
Role: STUDY_DIRECTOR
University of British Columbia
Locations
Explore where the study is taking place and check the recruitment status at each participating site.
BC Women's Hospital
Vancouver, British Columbia, Canada
Countries
Review the countries where the study has at least one active or historical site.
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
H06-03385
Identifier Type: -
Identifier Source: org_study_id
More Related Trials
Additional clinical trials that may be relevant based on similarity analysis.